Home › Funds › Wealth Intelligence, LLC › ABT
Wealth Intelligence, LLC position in ABT
ABBOTT LABORATORIES · Health Care
Wealth Intelligence, LLC reported holding 10,180 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$1.0M, representing 0.48% of its reported portfolio and ranking #44 among its reported holdings. Wealth Intelligence, LLC has disclosed ABT holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-10-16 · Source: SEC EDGAR Form 13F-HR
How Wealth Intelligence, LLC's ABT position evolved
Wealth Intelligence, LLC first disclosed a stake in ABT in Q1 2026 at 7,523 shares (US$772K). The position peaked in Q3 2026 at 10,180 shares, worth US$1.0M. Across 3 filings, Wealth Intelligence, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 10,180 shares valued at US$1.0M — an increase of 2,148 shares quarter over quarter.. Notable position changes include a 27% increase in Q3 2026 (shares rose 11% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 7.52K | $772.39K | New |
| Q2 2026 | 8.03K | $728.82K | Add |
| Q3 2026 | 10.18K | $1.01M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ABT and 13F data
ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ABT
- Vanguard Group 175.56M sh · $22.00B · Q4 2025
- Charles Schwab Investment Management 59.67M sh · $5.41B · Q2 2026
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC 59.67M sh · $5.41B · Q2 2026
- Sixth Street Partners Management Company, L.P. 59.67M sh · $5.41B · Q2 2026
- Capital Research Global Investors 36.91M sh · $3.35B · Q2 2026
- Capital Research Global Investors 36.91M sh · $3.35B · Q2 2026
- Capital International Investors 34.65M sh · $3.15B · Q2 2026
- Deutsche Bank AG 16.71M sh · $1.52B · Q2 2026
More on Wealth Intelligence, LLC
FAQ
How long has Wealth Intelligence, LLC held ABT?
Wealth Intelligence, LLC has disclosed ABT holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Wealth Intelligence, LLC's current position in ABT?
As of Q3 2026, Wealth Intelligence, LLC holds 10.18K shares of ABT (ABBOTT LABORATORIES), valued at $1.01M, representing 0.48% of its reported portfolio and ranking #44.
Has Wealth Intelligence, LLC been buying or selling ABT?
In the latest 13F filing (Q3 2026), Wealth Intelligence, LLC increased its position in ABT. The position peaked in Q3 2026 at 10.18K shares.
Which other funds hold ABT?
Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.